BackgroundCurrent methods of measuring disease progression of neurodegenerative disorders, including Parkinson's disease (PD), largely rely on composite clin...| Frontiers
Explore Clario’s Opal®️ V2C precision motion monitoring and actigraphy solution for digital biomarker endpoint measurement in clinical trials.| Clario
By leveraging digital endpoints, clinical trials can be more patient-centric, data-driven, and adaptable to meet the evolving needs of healthcare research.| DATAcc by DiMe
DATAcc Projects DATAcc projects focus on advancing digital health measurements by developing new evidentiary frameworks and new measures in a pre-competitive environment. As a DATAcc project partner, you will be part of a project to transform lives with digital health measurement. Your organization will also become a member of the DATAcc steering committee and community. […]| DATAcc by DiMe
